Dendritic cell vaccination and immune monitoring

被引：0
|
作者：
E. H. J. G. Aarntzen
C. G. Figdor
G. J. Adema
C. J. A. Punt
I. J. M. de Vries
机构：
[1] Nijmegen Centre for Molecular Life Sciences,Department of Medical Oncology
[2] Radboud University Nijmegen Medical Centre,Department of Tumor Immunology
[3] Nijmegen Centre for Molecular Life Sciences,Department of Pediatric Hemato
[4] Radboud University Nijmegen Medical Centre,Oncology
[5] Nijmegen Centre for Molecular Life Sciences,undefined
[6] Radboud University Nijmegen Medical Centre,undefined
来源：
Cancer Immunology, Immunotherapy | 2008年 / 57卷
关键词：
Dendritic cells; Specific immune responses; Migration; mRNA transfection; In vivo targeting;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
We exploited dendritic cells (DC) to vaccinate melanoma patients. We recently demonstrated a statistical significant correlation between favorable clinical outcome and the presence of vaccine-related tumor antigen-specific T cells in delayed type hypersensitivity (DTH) skin biopsies. However, favorable clinical outcome is only observed in a minority of the treated patients. Therefore, it is obvious that current DC-based protocols need to be improved. For this reason, we study in small proof of principle trials the fate, interactions and effectiveness of the injected DC.
引用
收藏
页码：1559 / 1568
页数：9
相关论文
共 50 条
  • [31] Liposomal meningococcal B vaccination: Role of dendritic cell targeting in the development of a protective immune response
    Arigita, C
    Bevaart, L
    Everse, LA
    Koning, GA
    Hennink, WE
    Crommelin, DJA
    van de Winkel, JGJ
    van Vugt, MJ
    Kersten, GFA
    Jiskoot, W
    INFECTION AND IMMUNITY, 2003, 71 (09) : 5210 - 5218
  • [32] Breaking immune tolerance in chronic hepatitis B by dendritic cell vaccination in HBV trimera mice
    Vuyyuru, RR
    Rahman, FK
    Schmitt, S
    Herzog-Hauff, S
    Tavakoli, S
    Weyer, S
    Koeck, J
    Geissler, M
    Strand, D
    Galle, P
    Bocher, WO
    HEPATOLOGY, 2004, 40 (04) : 664A - 664A
  • [33] Myeloid-derived Suppressor Cell and Regulatory T Cell Immune Monitoring of Soft Tissue Sarcoma Patients Undergoing Combination External Beam Radiation and Intratumoral Dendritic Cell Vaccination
    Iclozan, C. D.
    Cotter, M. J.
    Ramakrishnan, R.
    Lenox, B. C.
    Bui, M. M.
    Letson, G. D.
    Antonia, S. J.
    Gabrilovich, D. I.
    Finkelstein, S. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S657 - S658
  • [34] Dendritic cell dendritic cell interactions in primary immune responses.
    Knight, SC
    Bedford, PA
    Garner, K
    Kelleher, P
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, : 11 - 11
  • [35] Granulocyte-to-dendritic cell-ratio as marker for the immune monitoring in patients with renal cell carcinoma
    Riemann, Dagmar
    Hase, Sabine
    Fischer, Kersten
    Seliger, Barbara
    CLINICAL AND TRANSLATIONAL MEDICINE, 2014, 3
  • [36] Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients
    Timmerman, JM
    Czerwinski, DK
    Davis, TA
    Hsu, FJ
    Benike, C
    Hao, ZM
    Taidi, B
    Rajapaksa, R
    Caspar, CB
    Okada, CY
    van Beckhoven, A
    Liles, TM
    Engleman, EG
    Levy, R
    BLOOD, 2002, 99 (05) : 1517 - 1526
  • [37] Advances in dendritic cell vaccination therapy of cancer
    Najafi, Sajad
    Mortezaee, Keywan
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 164
  • [38] Dendritic cell vaccination in acute myeloid leukemia
    Anguille, Sebastien
    Willemen, Yannick
    Lion, Eva
    Smits, Evelien L.
    Berneman, Zwi N.
    CYTOTHERAPY, 2012, 14 (06) : 647 - 656
  • [39] The Role of Dendritic Cells in Immune Control and Vaccination against γ-Herpesviruses
    Munz, Christian
    VIRUSES-BASEL, 2019, 11 (12):
  • [40] Dendritic cell vaccination as a treatment modality for melanoma
    Eubel, Jana
    Enk, Alexander H.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (11) : 1631 - 1642
12345